IHC staining analyses of 54 NSCLC tumors using antibodies that detect antigens mapped to exon 1 and exon 11 of BARD1 showed the highest expression of BARD1 in large cell carcinoma followed by squamous cell carcinoma then adenocarcinoma [122]. This evidence concerns the gene BARD1 and squamous cell carcinoma.